Company type | Public |
---|---|
BSE: 500660 NSE: GLAXO | |
Industry | Pharmaceuticals & healthcare |
Predecessor | Laboratories (I) Ltd |
Founded | 13 November 1924[1] | as H. J. Foster & Co. Limited
Headquarters | , India |
Products | Medicines and vaccines |
Revenue | ₹3,309 crore (US$400 million) (FY 2021)[2] |
₹358 crore (US$43 million) (FY 2021)[2] | |
Number of employees | 3500[3] |
Parent | GSK |
Website | india-pharma |
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK.[4][5] The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others.[6]